UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient-physician discordance in goals of care for patients with advanced cancer

Current oncology (Toronto), 2019-12, Vol.26 (6), p.370-379

2019

Volltextzugriff (PDF)

Brain metastases, treatment patterns and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Annals of oncology, 2019-11, Vol.30, p.ix25-ix26

2019

Volltextzugriff (PDF)

Brain metastases, treatment patterns and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Annals of oncology, 2019-10, Vol.30, p.v639

2019

Volltextzugriff (PDF)

Biomarker status as a mediator of age-related overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)

Annals of oncology, 2019-10, Vol.30, p.v642

2019

Volltextzugriff (PDF)

1558P - Biomarker status as a mediator of age-related overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)

Annals of oncology, 2019-10, Vol.30, p.v642-v642

2019

Volltextzugriff (PDF)

1551P - Brain metastases, treatment patterns and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Annals of oncology, 2019-10, Vol.30, p.v639-v639

2019

Volltextzugriff (PDF)

Rectal Cancer Outcome Study Based on Multiple NRG Oncology Clinical Trials with Random Survival Forests

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S168-S168

2017

Volltextzugriff (PDF)

Disparities in Access and Treatment of Patients With High-Risk Prostate Cancer: Results From a Population-Based Cohort

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E258-E258

2016

Volltextzugriff (PDF)

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers: Attitudinal barriers for cancer clinical trials

European journal of cancer care, 2015-01, Vol.24 (1), p.28-38

2015

Volltextzugriff (PDF)

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

European journal of cancer care, 2015-01, Vol.24 (1), p.28-38

2015

Volltextzugriff (PDF)

The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial

Psycho-oncology (Chichester, England), 2013-03, Vol.22 (3), p.481-489

2013

Volltextzugriff (PDF)

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer

Annals of oncology, 2013-02, Vol.24 (2), p.420-428

2013

Volltextzugriff (PDF)

Longitudinal Quality of Life (QOL) and Patient-Reported Bowel Function in RTOG 0247

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S98-S98

2011

Volltextzugriff (PDF)

PRM55 A New Approach to Modeling Cancer Recurrence and Follow-Up

Value in health, 2011, Vol.14 (7), p.A430-A431

2011

Volltextzugriff (PDF)

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

Annals of oncology, 2009-07, Vol.20 (7), p.1223-1229

2009

Volltextzugriff (PDF)

The Role of Qualitative Analysis of F18-FDG Positron Emission Tomography in Predicting Pathologic Response following Chemoradiotherapy in Patients with Esophageal Carcinoma

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S271-S272

2009

Volltextzugriff (PDF)

Normal Tissue Complication Probability (NTCP) Modeling of Cardiac Toxicity in Patients with Esophageal Cancer Undergoing Chemoradiation

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S164-S164

2009

Volltextzugriff (PDF)

The Effect of Gender and Dose on the Development of Symptomatic Cardiac Toxicity after Chemoradiotherapy for Esophageal Carcinoma

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S254-S254

2008

Volltextzugriff (PDF)

Radiation Therapy in Gallbladder Cancer Treatment: The Fox Chase Cancer Center Experience

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S301-S301

2007

Volltextzugriff (PDF)

3014 (Presidential session, Tue 25 Sep 12.30–14.30) ORAL Association of somatic KRAS gene mutations and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) receiving panitumumab monotherapy

European journal of cancer supplements, 2007, Vol.5 (4), p.239-239

2007

Volltextzugriff (PDF)

3019 POSTER Association of gene copy number (GCN) of the epidermal growth factor receptor (EGFr) and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab monotherapy

European journal of cancer supplements, 2007, Vol.5 (4), p.241-241

2007

Volltextzugriff (PDF)

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200

Annals of oncology, 2006-09, Vol.17 (9), p.1399-1403

2006

Volltextzugriff (PDF)

117 Negative post-treatment 18-FDG pet scans may not predict pathologic complete response in patients with rectal cancer undergoing neoadjuvant chemoradiation

Radiotherapy and oncology, 2006-03, Vol.78, p.S37-S37

2006

Volltextzugriff (PDF)

30 A phase I clinical trial of HGS-ETR1, an agonist monoclonal antibody to TRAIL-R1, in patients with advanced solid tumors

European journal of cancer supplements, 2004-09, Vol.2 (8), p.13-13

2004

Volltextzugriff (PDF)

Telomerase is Frequently Activated in Tumors with Microsatellite Instability

Cancer biology & therapy, 2004-03, Vol.3 (3), p.289-292

2004

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Oncology
(10)
Hematology, Oncology And Palliative Medicine
(8)
Humans
(8)
Aged
(6)
Biological And Medical Sciences
(6)
Female
(6)
Middle Aged
(6)
Radiology
(6)
Antineoplastic Agents
(5)
Male
(5)
Medical Sciences
(5)
Pharmacology. Drug Treatments
(5)
Colorectal Cancer
(4)
Colorectal Neoplasms - Drug Therapy
(4)
Adult
(3)
Aged, 80 And Over
(3)
Cancer
(3)
Disease-Free Survival
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient-physician discordance in goals of care for patients with advanced cancer

Brain metastases, treatment patterns and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Brain metastases, treatment patterns and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Biomarker status as a mediator of age-related overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)

1558P - Biomarker status as a mediator of age-related overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)

1551P - Brain metastases, treatment patterns and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Rectal Cancer Outcome Study Based on Multiple NRG Oncology Clinical Trials with Random Survival Forests

Disparities in Access and Treatment of Patients With High-Risk Prostate Cancer: Results From a Population-Based Cohort

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers: Attitudinal barriers for cancer clinical trials

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer

Longitudinal Quality of Life (QOL) and Patient-Reported Bowel Function in RTOG 0247

PRM55 A New Approach to Modeling Cancer Recurrence and Follow-Up

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

The Role of Qualitative Analysis of F18-FDG Positron Emission Tomography in Predicting Pathologic Response following Chemoradiotherapy in Patients with Esophageal Carcinoma

Normal Tissue Complication Probability (NTCP) Modeling of Cardiac Toxicity in Patients with Esophageal Cancer Undergoing Chemoradiation

The Effect of Gender and Dose on the Development of Symptomatic Cardiac Toxicity after Chemoradiotherapy for Esophageal Carcinoma

Radiation Therapy in Gallbladder Cancer Treatment: The Fox Chase Cancer Center Experience

3014 (Presidential session, Tue 25 Sep 12.30–14.30) ORAL Association of somatic KRAS gene mutations and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) receiving panitumumab monotherapy

3019 POSTER Association of gene copy number (GCN) of the epidermal growth factor receptor (EGFr) and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab monotherapy

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200

117 Negative post-treatment 18-FDG pet scans may not predict pathologic complete response in patients with rectal cancer undergoing neoadjuvant chemoradiation

30 A phase I clinical trial of HGS-ETR1, an agonist monoclonal antibody to TRAIL-R1, in patients with advanced solid tumors

Telomerase is Frequently Activated in Tumors with Microsatellite Instability

Suchergebnisse filtern